Level Four Advisory Services’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-5,340
Closed -$218K – 561
2019
Q4
$218K Sell
5,340
-320
-6% -$12.6K 0.01% 525
2019
Q3
$201K Buy
5,660
+495
+10% +$20.1K 0.02% 481
2019
Q2
$265K Buy
5,165
+95
+2% +$4.74K 0.03% 446
2019
Q1
$291K Buy
+5,070
New +$251K 0.03% 421

Other funds holding RGNX

Level Four Advisory Services's RGNX Position: Q1 2020 in Review

Level Four Advisory Services sold out of Regenxbio (RGNX) in Q1 2020, closing a stake of 5,340 shares — an estimated $218K sold.

Level Four Advisory Services first reported a position in RGNX in Q1 2019 and held it in 4 quarters. The position peaked at $291K in Q1 2019. 170 funds tracked by Wall St. Rank hold RGNX as of Q1 2020.

  • Level Four Advisory Services reported no remaining Regenxbio position as of Q1 2020 after selling out during the quarter.
  • Level Four Advisory Services sold 5,340 Regenxbio shares in Q1 2020, an estimated $218K.
  • Level Four Advisory Services first reported a position in Regenxbio in Q1 2019 and held it in 4 quarters.
  • Level Four Advisory Services's Regenxbio position peaked at $291K in Q1 2019.
  • 170 funds tracked by Wall St. Rank held Regenxbio as of Q1 2020.

Based on Level Four Advisory Services's 13F filing for Q1 2020, filed 13 May 2020.